Clinical trial

Better Risk Perception Via Patient Similarity to Control Hyperglycemia and Sustained by Telemonitoring

NCT06607497

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2024-07-15

PhaseNA

Study timeline

Study start (actual)2024-07-15Date precision: day

Registry last updated2026-05-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

Intervention using an AI enabled risk communication tool (PERDICT.AI)OTHER

Telemonitoring with Primary Tech Enhanced Care (PTEC-DM)OTHER

Sponsors & collaborators

SingHealth Polyclinicslead sponsor

AISG Health Grand Challengecollaborator

Mapped research locations

SingaporeSingapore1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06607497 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.